Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gallicano

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|February 1, 1995
Application issues in bioanalytical method validation, sample analysis and data reportingD Dadgar, P E Burnett, M G Choc, et al.
British Journal of Clinical Pharmacology|August 1, 1993
Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patientsK Gallicano, J Sahai, E Ormsby, et al.
Clinical Pharmacology and Therapeutics|March 1, 1993
Cations in the didanosine tablet reduce ciprofloxacin bioavailabilityJ Sahai, K Gallicano, L Oliveras, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 24, 1999
Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavirS Kravcik, K Gallicano, V Roth, et al.
British Journal of Clinical Pharmacology|June 1, 1992
The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patientsJ Sahai, K Gallicano, G Garber, et al.
British Journal of Clinical Pharmacology|August 10, 2000
Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver diseaseY Khaliq, K Gallicano, I Seguin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2000
Patient-reported nonadherence to HAART is related to protease inhibitor levelsR Murri, A Ammassari, K Gallicano, et al.
Clinical Pharmacology and Therapeutics|November 1, 1992
Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virusJ Sahai, K Gallicano, G Garber, et al.
Annals of Internal Medicine|August 15, 1997
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infectionJ Sahai, K Gallicano, L Swick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2002
Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreakP Spradling, D Drociuk, S McLaughlin, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical and Biomedical Analysis|February 1, 1995
Application issues in bioanalytical method validation, sample analysis and data reportingD Dadgar, P E Burnett, M G Choc, et al.
British Journal of Clinical Pharmacology|August 1, 1993
Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patientsK Gallicano, J Sahai, E Ormsby, et al.
Clinical Pharmacology and Therapeutics|March 1, 1993
Cations in the didanosine tablet reduce ciprofloxacin bioavailabilityJ Sahai, K Gallicano, L Oliveras, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 24, 1999
Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavirS Kravcik, K Gallicano, V Roth, et al.
British Journal of Clinical Pharmacology|June 1, 1992
The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patientsJ Sahai, K Gallicano, G Garber, et al.
British Journal of Clinical Pharmacology|August 10, 2000
Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver diseaseY Khaliq, K Gallicano, I Seguin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2000
Patient-reported nonadherence to HAART is related to protease inhibitor levelsR Murri, A Ammassari, K Gallicano, et al.
Clinical Pharmacology and Therapeutics|November 1, 1992
Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virusJ Sahai, K Gallicano, G Garber, et al.
Annals of Internal Medicine|August 15, 1997
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infectionJ Sahai, K Gallicano, L Swick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2002
Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreakP Spradling, D Drociuk, S McLaughlin, et al.
Pageof 4